An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-8 | Issue-02
Prevalence of Thrombocytopenia during Pregnancy & Its Effect on Pregnancy & Neonatal Outcome
Dr. Sarita Godara, Dr. Lila Vyas, Dr. Narendra
Published: Feb. 27, 2020 | 91 103
DOI: 10.36347/sjams.2020.v08i02.057
Pages: 681-684
Downloads
Abstract
Background: To study the Prevalence of thrombocytopenia during pregnancy and its effect on pregnancy and neonatal outcome. Methods: It was a prospective 6 month study of pregnancy with thrombocytopenia. The cause of thrombocytopenia and feto-maternal outcomes in pregnancy with thrombocytopenia was studied. Results: Among 3790 deliveries, total 100 women were having thrombocytopenia. The commonest etiology was gestational thrombocytopenia 66%. Maternal complications was Placental abruption 5%, PPH 9%, episiotomy hematoma 5%, C.S. wound hematoma 1%,whole blood &PRBC transfusion 26%, platelet transfusion 23%, FFP transfusion 10% and ICU admission 7% were noted. Fetal complications were–APGAR score at 1 min. (<7) 59%, APGAR score at 5 min. (<7) 43%, IUFD 2%, NICU admission 21%, and neonatal thrombocytopenia 1%, IUGR 4%. Conclusion: Feto-maternal complications with thrombocytopenia depend primarily on the disease causing it. Gestational thrombocytopenia is most common cause of thrombocytopenia, preeclampsia, HELLP syndrome, malaria, ITP and dengue were other causes of thrombocytopenia in pregnant. Patients with Gestational thrombocytopenia have better maternal and peri-natal outcomes as compared to preeclampsia and HELLP syndrome.